COMPARING COST-UTILITY OF DMARDs IN AUTOANTIBODY-NEGATIVE RHEUMATOID ARTHRITIS PATIENTS.
Sign Up to like & getrecommendations! Published in 2021 at "Rheumatology"
DOI: 10.1093/rheumatology/keab251
Abstract: OBJECTIVES To evaluate the 1-year cost-effectiveness between three different initial treatment strategies in autoantibody-negative rheumatoid arthritis(RA-) patients, according to 2010 criteria. MATERIALS AND METHODS For this analysis we selected all RA- patients within the intermediate… read more here.
Keywords: negative rheumatoid; ihcq; arthritis patients; autoantibody negative ... See more keywords